The Evidence for the Use of Recombinant Human Activated Factor VII in the Treatment of Bleeding Patients With Quantitative and Qualitative Platelet Disorders
Author:
Publisher
Elsevier BV
Subject
Biochemistry (medical),Clinical Biochemistry,Hematology
Reference102 articles.
1. Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets;Gelb;Transfusion,1997
2. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population;Dodd;Transfusion,2002
3. Don't bug me: the problem of bacterial contamination of blood components—Challenges and solutions;Jacobs;Transfusion,2001
4. Bacterial contamination of blood components;Engelfriet;Vox Sang,2000
5. Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia;Poon;Blood,1999
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. AryoSeven RT (Coagulation factor VIIa, recombinant) safety and efficacy study among congenial factor VII deficient patients in Iraq;Iraqi Journal of Hematology;2022
2. Novel factor VII gene mutations in six families with hereditary coagulation factor VII deficiency;Journal of Clinical Laboratory Analysis;2021-08-02
3. Learning the Ropes of Platelet Count Regulation: Inherited Thrombocytopenias;Journal of Clinical Medicine;2021-02-02
4. Neonatal thrombocytopenia: Thrombin generation in presence of reduced platelet counts and effects of rFVIIa in cord blood;Scientific Reports;2019-05-29
5. Patient Blood Management;Risk Management in Transfusion Medicine;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3